haleon news - Search News

Pfizer sells further shares in Sensodyne maker Haleon

Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon

Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.

Bloomberg L.P. · 6d

Pfizer Raises $3.2 Billion by Selling Part of Haleon Stake

Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.

The Mirror · 5d

Pfizer sells stake in Sensodyne and Panadol maker Haleon worth around £2.4bn

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6%

46m

Futura Medical due $5m milestone payment from Haleon

Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been ...

Pfizer gins up £2.4B after unloading hundreds of millions of Haleon shares

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Drug Store News2d

Dr. Reddy’s completes acquisition of Haleon’s Nicotinell

The acquired portfolio includes Nicotinell, also known as Nicabate in Australia, Thrive in Canada and Habitrol in New Zealand and Canada.

6d

Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager

Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...

4d

World Street | Open AI's valuation soars to $150 bln, Pfizer's stake sale in Haleon, Yen weakens and more

From Tesla's persisting problems to Formula One and LVMH's latest 10-year long tie-up, here's a look at some of the major ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results